U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07117214) titled 'A Phase I Study of [68Ga]Ga-DWJ155 in Patients With Breast and Lung Cancers' on July 22.
Brief Summary: This is a phase I, open label first in human study to evaluate the imaging performance, safety, biodistribution and pharmacokinetics of [68Ga]Ga-DWJ155 in patients >= 18 years of age with hormone receptor positive/HER2 negative (HR+/HER2-) and HER2 positive (HER2+) advanced breast cancer (aBC) and advanced Non-Small Cell Lung Cancer (aNSCLC) adenocarcinoma.
Study Start Date: Aug. 20
Study Type: INTERVENTIONAL
Condition:
Breast Neoplasms
Carcinoma, Non-Small-Cell Lung
Intervention:
DRUG: [68Ga]Ga-DWJ155
Radioligand imaging a...